NKX3-1 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q99801 |
---|---|
Clone Names | 100427213 |
Gene ID | 4824 |
---|---|
Other Names | Homeobox protein Nkx-31, Homeobox protein NK-3 homolog A, NKX3-1, NKX31, NKX3A |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NKX3-1 (HGNC:7838) |
---|---|
Function | Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells. |
Cellular Location | Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:11137288} |
Tissue Location | Highly expressed in the prostate and, at a lower level, in the testis. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The homeodomain-containing transcription factor NKX3-1 isa putative prostate tumor suppressor that is expressed in a largelyprostate-specific and androgen-regulated manner. Loss of NKX3-1protein expression is a common finding in human prostate carcinomasand prostatic intraepithelial neoplasia.
References
Kim, S.T., et al. Prostate 70(16):1729-1738(2010)Takata, R., et al. Nat. Genet. 42(9):751-754(2010)Gurel, B., et al. Am. J. Surg. Pathol. 34(8):1097-1105(2010)Bowen, C., et al. Cancer Res. 70(8):3089-3097(2010)Kunderfranco, P., et al. PLoS ONE 5 (5), E10547 (2010) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.